Pulmobiotics declares voluntary bankruptcy and closes its registration file

Pulmobiotics, S.L., a biotechnology company based in Barcelona, has been declared in voluntary bankruptcy and its registration record has been provisionally closed. The Official Gazette of the Mercantile Registry (BORME) publishes the act in issue number 181, dated September 18, 2026, First Section, page 44161, with the official reference BORME-A-2026-181-08 and entry number 419231. The procedure, processed before the Commercial Section of the Court of First Instance of Barcelona (plaza 9), bears number 429/2026.

The announcement is registered under the “Other concepts” section of the First Section (Entrepreneurs, registered acts) and corresponds to the company with registration record H B 548089, volume 47470, section 8. The registration was carried out on September 10, 2026 (entry I/A 12) and its publication in the BORME grants it official publicity toward third parties.

Chronology of the bankruptcy procedure

• April 24, 2026: final court order declaring voluntary bankruptcy.
• June 30, 2026: final court order concluding the bankruptcy and provisional closure of the registration record.
• September 10, 2026: registration in the Mercantile Registry (I/A 12).
• September 18, 2026: publication in BORME no. 181.

The official text does not detail the liabilities or assets of the bankrupt entity, nor does it identify any bankruptcy administrator: it is limited to providing a registry record of the declaration and the conclusion of the procedure.

A biotechnology company incorporated in 2020

Pulmobiotics, S.L. was incorporated, commencing operations on March 26, 2020, and was registered on May 13, 2020. Its corporate purpose encompasses the research, development, innovation, production, manufacture, commercialization, exploitation, distribution, and the import and export of pharmaceutical, biotechnological, and healthcare products.

• Initial capital: 3,000 euros.
• Increase of 1,607.14 euros in June 2020 (resulting capital: 4,607.14 euros).
• Increase of 535.72 euros in November 2021 (resulting capital: 5,142.86 euros).
• Successive addresses: Sant Cugat del Vallès (2020), Vilamari 86-88 street in Barcelona (2020), and Passeig de Gràcia 54, 2º D in Barcelona (2022).

Management bodies and startup

Throughout its registration history, the company renewed its governing bodies. The initial sole administrator was Claudio Joao Ribeiro dos Santos, replaced in June 2020 by a board composed of Alberto Ferrer Oliveras, Luis García Pareras (president), Maria Lluch Senar, Luis Felipe Serrano Pubul, and Claudio Joao Ribeiro dos Santos himself, with Óscar Alegre Ribalta as non-director secretary.

• Edgardo Alberto Ferran: director since June 2020 and removed in April 2023.
• Timothy K. Lu: director since June 2022.
• Johannes Epeues Theodoor van Hylckama Vlieg: director since April 2024.
• April 30, 2024: acquisition of startup status under Law 28/2022, with a benefit enjoyment period of 7 years.

Reading for suppliers and creditors

The provisional closure of the registration sheet is the company’s last published act and serves as evidence that the insolvency proceedings were declared and concluded in barely two months. For suppliers, creditors, and partners, the entry is the official reference that certifies the registration status of Pulmobiotics, S.L. and allows for the verification of its status before the Mercantile Registry.

The publication in the BORME turns the case into an operational notice: any third party maintaining commercial or credit relations with the company now has a registered and published act that certifies both the declaration of voluntary insolvency 429/2026 as well as its conclusion and the provisional closure of the sheet, without the official announcement providing further data on the assets or the affected creditors.

Source: Official Gazette of the Mercantile Registry, no. 181, September 18, 2026, First Section, page 44161 (official reference: BORME-A-2026-181-08).